NCT03566667View on ClinicalTrials.gov

Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

1,713

Participants

Timeline

Start Date

June 12, 2018

Primary Completion Date

December 1, 2025

Study Completion Date

April 30, 2026

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Metoprolol

Betablocker

DRUG

Standard care

Standard care

Trial Locations (1)

701 85

University Hospital of Örebro, Örebro

All Listed Sponsors

lead

Ole Frobert, MD, PhD

OTHER